Evidence map›Paper›PMID 20478923›Full record

ArticleCarcinogenesis2010

Associations between NBS1 polymorphisms, haplotypes and smoking-related cancers.

Sungshim L Park, Delara Bastani, Binh Y Goldstein, Shen-Chih Chang, Wendy Cozen, Lin Cai, Carlos Cordon-Cardo, Baoguo Ding, Sander Greenland, Na He and 20 more

Open access · bronzeAbstract read
In one paragraph

Article in Carcinogenesis, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 3 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 3 syntheses or guidelines pooled it, 39 citations in OpenAlex.

  1. NBS1 Glu185Gln polymorphism and susceptibility to urinary system cancer: a meta-analysis.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Pooled it
  2. Association between the NBS1 Glu185Gln polymorphism and breast cancer risk: a meta-analysis.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2013
    Pooled it
  3. Pooled it
  4. Trial
  5. Review
  6. Article
  7. Article
  8. Characterization and strong risk association ofWorld journal of gastrointestinal oncology · 2020
    Article
  9. Article
  10. Review
  11. A non-synonymous polymorphism inOncoTargets and therapy · 2018
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 11 institutions in 2 countries.

Sungshim L ParkDepartment of Epidemiology, School of Public Health, University of California, Los Angeles, 71-225 CHS, Box 951772, 650 Charles E Young Drive, South, Los Angeles, CA 90095-1772, USA.
Delara Bastani
Binh Y Goldstein
Shen-Chih Chang
Wendy Cozen
Lin Cai
Carlos Cordon-Cardo
Baoguo Ding
Sander Greenland
Na He
Shehnaz K Hussain
Qingwu Jiang
Yuan-Chin A Lee
Simin Liu
Ming-Lan Lu
Thomas M Mack
Jenny T Mao
Hal Morgenstern
Li-Na Mu
Sam S Oh
Allan Pantuck
Jeanette C Papp
Jianyu Rao
Victor E Reuter
Donald P Tashkin
Hua Wang
Nai-Chieh Y You
Shun-Zhang Yu
Jin-Kou Zhao
Zuo-Feng Zhang
University of California, Los Angeles · USFudan University · CNJiangsu Provincial Center for Disease Control and Prevention · CNMemorial Sloan Kettering Cancer Center · USUniversity of Southern California · USColumbia University Irving Medical Center · USFujian Medical University · CNNew Mexico VA Health Care System · USTaixing People's Hospital · CNUniversity at Buffalo, State University of New York · USUniversity of Michigan–Ann Arbor · US

Funding

UCLA CANCER EPIDEMIOLOGY TRAINING PROGRAMT32CA009142 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ZHANG, ZUO-FENG · 1986 to 2024
$6.3M
LUNG CANCER CHEMOPREVENTION WITH CELECOXIB IN EX-SMOKERSU01CA096134 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MAO, JENNY T · 2002 to 2007
$5.1M
Stem Cell Selection &Expansion Via HOX Gene ActivationR01CA090833 · NCI · UNIVERSITY OF PENNSYLVANIA · PI EMERSON, STEPHEN G · 2001 to 2010
$2.6M
MARIJUANA USE AND THE RISKS OF LUNG AND OTHER CANCERSR01DA011386 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MORGENSTERN, HAL M · 1999 to 2003
$1.8M
Molecular Epidemiology of B cell Activation, DNA Repair & HIV-Associated LymphomaK07CA140360 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HUSSAIN, SHEHNAZ KHURSHEED · 2010 to 2014
$623k
MOLECULAR EPIDEMIOLOGY OF BLADDER CANCERR01ES006718 · NIEHS · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI ZHANG, ZUO-FENG · 1993 to 1995
–
HELICOBACTER PYLORI MALNUTRITION AND GASTRIC CANCERR03CA077954 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ZHANG, ZUO-FENG · 1997 to 1998
–
NCI NIH HHS CA077954NCI NIH HHS CA09142NCI NIH HHS CA90833NCI NIH HHS CA96134NCI NIH HHS K07 CA140360NCI NIH HHS R01 CA090833NCI NIH HHS R03 CA077954NCI NIH HHS T32 CA009142NCI NIH HHS U01 CA096134NIDA NIH HHS DA11386NIDA NIH HHS R01 DA011386NIEHS NIH HHS ES01167NIEHS NIH HHS ES06718
6 · The paper itself

Abstract

Constituents of tobacco smoke can cause DNA double-strand breaks (DSBs), leading to tumorigenesis. The NBS1 gene product is a vital component in DSB detection and repair, thus genetic variations may influence cancer development. We examined the associations between NBS1 polymorphisms and haplotypes and newly incident smoking-related cancers in three case-control studies (Los Angeles: 611 lung and 601 upper aero-digestive tract (UADT) cancer cases and 1040 controls; Memorial Sloan-Kettering Cancer Center: 227 bladder cancer cases and 211 controls and Taixing, China: 218 esophagus, 206 stomach, 204 liver cancer cases and 415 controls). rs1061302 was associated with cancers of the lung [adjusted odds ratio (OR(adj)) = 1.6, 95% confidence interval (CI): 1.2, 2.4], larynx (OR(adj) = 0.56, 95% CI: 0.32, 0.97) and liver (OR(adj) = 1.7, 95% CI: 1.0, 2.9). Additionally, positive associations were found for rs709816 with bladder cancer (OR(adj) = 4.2, 95% CI: 1.4, 12) and rs1063054 with lung cancer (OR(adj) = 1.6, 95% CI: 1.0, 2.3). Some associations in lung and stomach cancers varied with smoking status. CAC haplotype was positively associated with smoking-related cancers: lung (OR(adj) = 1.7, 95% CI: 1.1, 2.9) and UADT (OR(adj) = 2.0, 95% CI: 1.1, 3.7), specifically, oropharynx (OR(adj) = 2.1, 95% CI: 1.0, 4.2) and larynx (OR(adj) = 4.8, 95% CI: 1.7, 14). Bayesian false-discovery probabilities were calculated to assess Type I error. It appears that NBS1 polymorphisms and haplotypes may be associated with smoking-related cancers and that these associations may differ by smoking status. Our findings also suggest that single-nucleotide polymorphisms located in the binding region of the MRE-RAD50-NBS1 complex or microRNA targeted pathways may influence tumor development. These hypotheses should be further examined in functional studies.

Indexed as

HaplotypesPolymorphism, Single NucleotideAdolescentAdultAgedCase-Control StudiesCell Cycle ProteinsFemaleHumansLinkage DisequilibriumLung NeoplasmsMaleMiddle AgedNeoplasmsNuclear ProteinsSmokingCell Cycle ProteinsNBN protein, humanNuclear Proteins

Identifiers

PMID20478923
PMCPMC2893801
OpenAlexW2117252893

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.